Home » Topics » BioWorld Science

BioWorld Science
RSS

Tenebio opens enrollment in phase I study of TNB-383B in relapsed or refractory multiple myeloma

June 12, 2019

Evestra divulges LIF and MDM2 inhibitors

June 12, 2019

Bristol-Myers Squibb patents TYK2 inhibitors

June 12, 2019

Immunicum reports partial responses in phase I/II trial of ilixadencel in GIST

June 12, 2019

NT-1195, a potential treatment for type 2 diabetes, shows promising preclinical results

June 12, 2019

Sanofi presents preliminary data from a first-in-human study of SAR-439859

June 12, 2019

Topline 12-week data reported from an ongoing phase IIb study of seladelpar in NASH

June 12, 2019

Pharming initiates phase I/II study of Ruconest in patients with pre-eclampsia

June 12, 2019

FDA clears IND for Sleeping Beauty TCR-T-cell therapy trial

June 12, 2019

FDA approves Keytruda for two new indications

June 12, 2019

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...